SCHEMBL7375285

SCHEMBL7375285

CCOC(=O)C(CC(=O)OC(C)(C)C)c1ccc(NC(=O)c2cccc(NC(=N)N)c2)cc1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 6/20 0.44
NPC1 O15118 5/20 0.44
MEN1 O00255 4/20 0.44
LMNA P02545 2/20 0.42
ITGB3 P05106 1/20 0.41
ITGA2B P08514 1/20 0.41
SMN1; SMN2 Q16637 4/20 0.41
RAB9A P51151 4/20 0.41
PLAU P00749 2/20 0.41
STAT3 P40763 1/20 0.41
MAPT P10636 3/20 0.40
F2 P00734 1/20 0.40
F7 P08709 1/20 0.40
ALDH1A1 P00352 1/20 0.40
MAPK1 P28482 1/20 0.40
NPSR1 Q6W5P4 1/20 0.40
CA12 O43570 1/20 0.39
CA1 P00915 1/20 0.39
CA2 P00918 1/20 0.39
CA9 Q16790 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7452939 0.91 KMT2A (0.41) KMT2ANPC1MEN1LMNAITGB3
SCHEMBL7376667 0.88 ITGB3 (0.52) KMT2ANPC1MEN1LMNAITGB3
SCHEMBL7375287 0.87 STAT3 (0.41) KMT2ANPC1MEN1LMNAITGB3
SCHEMBL7379927 0.86 KMT2A (0.45) KMT2ANPC1MEN1LMNAITGB3
SCHEMBL7380397 0.85 CASR (0.47) KMT2ANPC1MEN1ITGB3ITGA2B
SCHEMBL7456272 0.80 ITGB3 (0.46) KMT2ANPC1MEN1ITGB3ITGA2B
SCHEMBL7416608 0.79 ITGB3 (0.60) KMT2ANPC1MEN1LMNAITGB3
SCHEMBL7375970 0.79 ITGB3 (0.60) KMT2ANPC1MEN1LMNAITGB3
SCHEMBL7373486 0.75 ITGB3 (0.60) KMT2ANPC1MEN1ITGB3ITGA2B
SCHEMBL7384346 0.75 KMT2A (0.56) KMT2ANPC1MEN1ITGB3ITGA2B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0891325-B1 PARA-SUBSTITUTED PHENYLPROPANOIC ACID DERIVATIVES AS INTEGRIN ANTAGONISTS SEARLE & CO (US) 2002-02-06 EP claimed
EP-1157985-A1 Para- substituted phenylene derivatives and their use as integrin antagonists G.D. SEARLE & CO. (US) 2001-11-28 EP claimed
US-6251944-B1 (VITRONECTIN RECEPTOR) INTEGRIN ANTAGONIST, USEFUL FOR TREATING ANGIOGENESIS, TUMOR GROWTH, TUMOR METASTASIS, OSTEOPOROSIS AND HUMORAL HYPERCALCEMIA OF MALIGNANCY G. D. SEARLE & COMPANY 2001-06-26 US claimed
EP-0891325-A1 PARA-SUBSTITUTED PHENYLPROPANOIC ACID DERIVATIVES AS INTEGRIN ANTAGONISTS G.D. SEARLE & CO. (US) 1999-01-20 EP claimed
WO-1997036859-A1 PARA-SUBSTITUTED PHENYLPROPANOIC ACID DERIVATIVES AS INTEGRIN ANTAGONISTS G.D. SEARLE & CO. (US) 1997-10-09 WO claimed
EP-0891325-B1 PARA-SUBSTITUTED PHENYLPROPANOIC ACID DERIVATIVES AS INTEGRIN ANTAGONISTS SEARLE & CO (US) 2002-02-06 EP disclosed
EP-1157985-A1 Para- substituted phenylene derivatives and their use as integrin antagonists G.D. SEARLE & CO. (US) 2001-11-28 EP disclosed
US-6251944-B1 (VITRONECTIN RECEPTOR) INTEGRIN ANTAGONIST, USEFUL FOR TREATING ANGIOGENESIS, TUMOR GROWTH, TUMOR METASTASIS, OSTEOPOROSIS AND HUMORAL HYPERCALCEMIA OF MALIGNANCY G. D. SEARLE & COMPANY 2001-06-26 US disclosed